Related Experiment Video
Updated: Jun 12, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
The relationship between economic evaluations and HIV and AIDS treatment policies
Sarah Jane Taleski1, Khaled Ahmed, Alan Whiteside
1University of Toronto, Canada.
Purpose Of Review:
Economics, and specifically economic evaluations, are increasingly being utilized to provide treatment policy guidance to decision makers. This article reviews work that has contributed to understanding of the relationship.
Recent Findings:
There is a paucity of research explicitly investigating the association between economic evaluations and HIV and AIDS treatment policy. Where it does exist, it is weak. Factors contributing to the limited impact include lack of reliable and trusted data; absence of local cost-effectiveness data for different interventions; contradictory results; challenges associated with understanding complex economic/mathematical models; inefficient implementation of HIV and AIDS policies; inability to pursue long-term health planning needs; and political will.
Summary:
Consideration of the ways in which economic evaluations can have greater influence over HIV and AIDS policies is needed. The weak relationship between the two reflects the complicated and multifaceted decision-making process that is often influenced by socioeconomic and political factors. If an economic evaluation is to influence policy, then cognizance of this is important. Extending the economic toolkit to include broader-based models that incorporate political economy variables, but do not compromise on comprehension, validity and robustness, will offer better informed policy recommendations.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Hazard Ratio
For example, in a clinical trial evaluating a...
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Therapeutic Drug Monitoring: Affecting Factors

